Mice carrying a conditional prothrombin knockout allele (fII lox ) were established to develop an experimental setting for exploring the importance of thrombin in the maintenance of vascular integrity, the inflammatory response, and disease processes in adult animals. In the absence of Cre-mediated recombination, homozygous fII lox/lox mice or compound heterozygous mice carrying one fII lox allele and one constitutive-null allele were viable. Young adults exhibited neither spontaneous bleeding events nor diminished reproductive success. However, the induction of Cre recombinase in fII lox mice using the poly I:C-inducible Mx1-Cre system resulted in the rapid and near-complete recombination of the fII lox allele within the liver, the loss of circulating prothrombin, and profound derangements in coagulation function. Consistent with the notion that thrombin regulates coagulation and inflammatory pathways, an additional early consequence of reducing prothrombin was impaired antimicrobial function in mice challenged with S.
Introduction
Proteolytic conversion of prothrombin (fII) to the active serine protease thrombin is central to thrombus formation and the local containment of blood loss following vascular injury. Thrombin-mediated proteolysis directly controls platelet activation through the protease-activated receptors (e.g., PARs-1, -3, and -4) [1] [2] [3] , converts fibrinogen to fibrin, and enhances thrombus stability through the proteolytic activation of fXIII and thrombinactivated fibrinolysis inhibitor (TAFI). 4 The seminal regulatory role of thrombin is further emphasized by the fact that this key protease both positively regulates further thrombin generation through the activation of coagulation factors XI, VIII, and V, and negatively controls thrombin generation through the thrombomodulin-dependent activation of the natural anticoagulant, protein C. 4 Beyond the intense, long-term interest in thrombin-mediated proteolysis in the control of hemostasis, there has been increasing interest in the ability of thrombin to regulate a wide-spectrum of physiological and pathological processes that have little to do with traditional hemostatic plug formation, including embryonic development, tissue repair, the inflammatory response, and pathologic processes (e.g., malignancy, host defense, and inflammatory diseases).
The concept of a broad biological importance of thrombin was underscored by early developmental studies in gene-targeted mice lacking either prothrombin 5, 6 , factors that participate in thrombin generation (e.g., tissue factor, fVII, fV, and fX) [7] [8] [9] [10] [11] or selected thrombin substrates (e.g., PAR-1).
The broad biological actions of thrombin can be appreciated in part by the diversity of thrombin substrates. Changes in cellular function following the engagement of fibrin matrices by integrin and non-integrin receptors are undoubtedly one mode of thrombin action in vitro and in vivo. Thrombin-initiated PAR-1 and -4 signaling is likely to be an equally critical modifier of cellular function. Many other thrombin substrates have been tied to important biological processes, including protein C, 21 complement factors (e.g., C5), 22 immune-modulators (e.g., osteopontin), 23 HGF activator, 24 carboxypeptidase TAFI, 25 and fXIII. A particularly strong link has emerged between thrombin targets and the regulation of the inflammatory response and inflammatory disease. This has been strengthened by recent findings indicating that activated protein C (APC) has potent antiinflammatory properties that are distinct from its anticoagulant activity. 21, 26, 27 Furthermore, thrombin activation of PARs on platelets, endothelial cells and other cells can lead to the production of an impressive array of cytokines and chemokines, as well as changes in adhesive properties important in leukocyte trafficking and/or activation. [28] [29] [30] [31] [32] [33] Progress in defining the precise contribution of prothrombin and thrombin-mediated proteolysis in tissue remodeling/repair, antimicrobial response, inflammatory disease and other complex processes has been hampered by the inability to generate viable prothrombin-deficient adult mice. 5, 6 The constitutive loss of prothrombin (fII -/-) results in partial mid-gestation embryonic lethality. The small fraction of fII -/-offspring surviving to term develop fatal hemorrhagic events shortly after birth, and thus provided no means of exploring the role of prothrombin in adults. To investigate in greater detail the contribution of prothrombin/thrombin to physiological processes and diseases in vivo in adult animals, we have generated mice carrying a conditional knockout allele for prothrombin (fII lox ). Although a substantial constitutive reduction (e.g., 10-20% of normal) in circulating prothrombin was found to be compatible with long-term survival, the consequences of a more profound diminution in circulating prothrombin were severe, including reduced capacity for microbial clearance and fatal hemorrhagic events, particularly in the heart and brain.
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Materials and Methods

Transgenic mice
The prothrombin conditional knockout allele was generated using a targeting vector constructed by introducing the following four elements into plasmid pKO v901 (Stratagene, La Jolla, CA) that was modified to include loxP sites adjacent to the polylinker AscI site: i) a 3.7kb HPRT minigene (AscI cassette) (Stratagene); ii) a 2 kb herpes simplex virus thymidine kinase minigene (RsrII cassette) (Stratagene); iii) a 0.7kb "short arm" complementary to intron 9 and exon 10 sequences of the mouse prothrombin gene (see below for additional details); and iv) a 6.6kb "long arm" that draws together a 5' portion of the mouse prothrombin gene, a portion of the mouse prothrombin cDNA, and a 3' portion of the hGH gene (KpnI cassette). The 0.7kb "short arm" gene fragment was generated by PCR amplification using primers complementary to intron 9 (5'-GATCGGATCCTGGACTGATCTAC-3') and exon 10 (5'-GTACAGAATGCAGTCGACAGCAGTGAG-3'), but with nucleotide substitutions designed to introduce non-native BamHI and SalI sites (underlined). The "long arm" was constructed from three major components. yielding a 1.3kb PCR product. Homologous recombination was confirmed by a second similar strategy (HPRT and exon 12 -5'-CACCACCTGCAGGACGCTGGGCTGT-3' -specific primers; yielding a PCR product of 1.6kb). Germline-competent chimeric founder mice were generated using three ES cell isolates confirmed to have incorporated the targeting vector by homologous recombination by both PCR and Southern blot analyses. Mice carrying the prothrombin conditional knockout allele were backcrossed 6 generations to C57Bl/6J prior to detailed analyses and were routinely identified by PCR analysis of DNA obtained from ear biopsies using primers complementary to prothrombin intron 2 that flanked the LoxP insertion (forward primer F1: 5'-GCTCTTCCCCTTTTCAGACTTTCAC-3'; reverse primer B1: 5'-ACCTTATCCTTCCCTTACCACCTG-3') which yield products of 402bp and 438bp
with the wild-type and mutant allele templates, respectively. All experiments were approved by the CCHRF Animal Care and Use Committee and complied with NIH guidelines.
Conditional recombination of the mutant prothrombin allele
C57Bl/6-inbred mice carrying the poly I:C-inducible Mx1-Cre recombinase transgene 38 were obtained and genotyped per protocol (Jackson Laboratories, Bar Harbor, ME.). Figure 1A ). 5 The 0.9kb hybridization probe ( Figure 1 ) was generated by 
Northern blot analysis of hepatic prothrombin mRNA
Total hepatic RNA was extracted using STAT-60 (Iso-Tex, Friendswood, TX.).
Prothrombin mRNA was detected as described previously 39 using a 32 P-radiolabeled 1.1kb XhoI-EcoRV fragment derived from the coding portion of the murine fII cDNA. 
Hematological profiles, immunological analysis of prothrombin, and bleeding times
Whole blood, drawn from the inferior vena cava of anesthetized mice into 1/10 volume 0.1M citrate, was used for complete blood cell analysis or processed to prepare plasma. observation was terminated at 13 minutes in any animal that failed to stop bleeding. were anesthetized with isofluorane and injected i.p. with 1 x 10 9 S. aureus (Newman strain) in 1 ml of saline. One hour later, all mice were again anesthetized and the peritoneal cavity was lavaged with 5 ml of cold PBS. Dilutions of retrieved lavage fluids were plated on tryptic soy agar for determination of colony forming units. Plasma was harvested for determination of the circulating prothrombin concentration by Western blot as described above.
Statistical Analysis
Mouse survival was analyzed using the Kaplan-Meier statistical test. All other statistical comparisons were generated using the Mann-Whitney U test, except hematological parameters analyzed with the Fisher's exact test as indicated in Table 1 . ) established that the fII lox allele was transmitted to weaning age offspring with a Mendelian inheritance pattern. Here, given the expected absence 5, 6 of any viable homozygous fII -/-progeny, fII lox/-and fII lox/lox mice were found at near the expected 2:1 ratio (among 561 total progeny raised thus far, 359 were fII lox/-and 202 were fII lox/lox ).
The developmental and/or perinatal success of unchallenged fII lox/-mice was vastly superior to prothrombin-null fII -/-mice (which are uniformly not viable) and was comparable to previously described 39 transgenic mice expressing low levels (~7%) of human prothrombin. FII lox/-mice also survived well into adulthood, with the oldest mice now exceeding a year of age. Overt spontaneous hemorrhagic events were never appreciated in either fII lox/lox or fII lox/-mice at any age, and females were capable of carrying multiple litters to term (many have delivered five or more litters). Thus, carrying either one or two intact conditional prothrombin knockout alleles was sufficient to maintain normal development, growth and reproductive success.
Cre-mediated disruption of the hepatic fII gene and loss of circulating fII
To explore the consequences of a genetic loss of prothrombin in adult mice, fII Figure 1C ), but recombination events in the liver under these conditions were probably rare as they were not detectable by Southern blot analysis. Complementary gene expression studies at both the mRNA level ( Figure 1D ) and protein level ( Figure   1E ) established that fII lox/-mice lacking Cre recombinase had basal levels of prothrombin expression that were less than the expected value of 50% of wild-type. Specifically, quantitation of hepatic prothrombin mRNA by phosphoimager analysis of Northern blot data indicated that prothrombin expression was ~25% of wild-type in uninduced fII lox/-For personal use only. on May 4, 2017. by guest www.bloodjournal.org From mice. These data suggest that the novel organization of the intact fII lox allele, including the substitution of 3' noncoding and flanking sequences, resulted in a reduction in basal hepatic expression at the level of gene transcription and/or mRNA processing/half-life. In retrospect, this outcome is not that surprising given that noncoding polymorphisms in the human gene mRNA result in altered steady-state mRNA levels (e.g., the prothrombin G20210A polymorphism 41, 42 ). Consistent with the hepatic mRNA findings, immunological analyses of prothrombin in plasma samples collected from Cre-negative fII lox/-mice ( Figure 1E ) established that, even in the absence of recombination, these animals had low basal levels of circulating prothrombin (estimated to be 10-20% of wildtype mice). More impressively, the low levels of prothrombin expression in adult Mx + fII lox/-mice could be reduced to essentially undetectable levels at both the mRNA and 
Hematological consequences of genetic elimination of prothrombin in adult mice
Comparative analyses of complete blood counts in whole blood collected from adult Mx -fII lox/-and Mx + fII lox/-mice established that these animals retained blood cell profiles that
were not appreciably different from wild-type mice, with normal hemoglobin, platelet, and white blood cell counts (Table 1) . Coagulation analyses using standard PT and aPTT assays were only modestly prolonged in unchallenged fII lox/-mice relative to wild-type mice (Table 1) . In contrast, both of these prothrombin-sensitive clotting assays revealed a profound loss of clotting function in Mx + fII lox/-mice 6 days following the deletion of the fII lox allele. Indeed, neither tissue factor-nor contact-induced activation of the coagulation system resulted in clot formation for as long as the samples were observed.
Despite this profound impairment in clotting function, the platelet count in whole blood was not diminished in poly I:C-induced Mx + fII lox/-mice relative to wild-type controls ( Table 1 ), suggesting that in the absence of any significant hemorrhagic event the simple loss of coagulation function resulted in no major ongoing platelet consumption. There was also no significant fibrinogen consumption in fII lox/-mice carrying very low prothrombin. Here, prompt clot formation was observed in plasma following the addition loss in an average time that was only modestly longer than wild-type animals (2.4 +/-1.0 minutes; P < 0.002 vs. wild-type mice). However, the remaining 5 mice, while obviously successful in slowing blood loss, ultimately failed to fully stop blood flow and exhibited a pattern of delayed resumption in bleeding (presumably reflecting unstable thrombus formation). Thus, the low level of circulating prothrombin observed in fII lox/-mice appeared to be compatible with event-free survival, but it was low enough to be biologically meaningful in at least some individuals challenged with a relatively large combined venous and arterial mechanical injury.
Loss of prothrombin in adult mice results in fatal hemorrhagic events
Any phenotypic consequences of a conditional disruption of the prothrombin gene in adult mice would not be expected to be immediately obvious, as circulating prothrombin would be expected to decline as a function of both prothrombin mRNA and protein half- Microscopic analysis of brain sections confirmed that hemorrhage within the central nervous system was commonplace in adult Mx + fII lox/-mice genetically-depleted of prothrombin (11 of 21 mice evaluated microscopically; 53%), but was never encountered in Cre-negative control mice ( Figure 5 ). Although CNS bleeding often appeared to be dural based (see Figure 3 ), microscopic analysis of tissue sections established that ventricular and parenchymal hemorrhage events were commonplace, with parenchymal bleeding events frequently encountered in the medulla, cerebellum, and hippocampus ( Figure 5 ). 
Prothrombin-deficient mice exhibit an impediment in microbial clearance
The capacity to conditionally eliminate prothrombin in adult mice provided a novel opportunity to explore the prevailing notion that thrombin regulates both coagulation and inflammatory pathways. very few bacteria were noted in the control animals ( Figure 6 ). Western analysis of plasma obtained from the Mx + fII lox/lox animals that received poly I:C confirmed that the depletion of prothrombin was accomplished (data not shown).
Discussion
Prothrombin plays a premier role in thrombus formation and thrombotic disease in that it is the focal point of a regulatory nexus for the hemostatic system through the engagement of a wide array of substrates (e.g., fibrinogen, fXI, fVIII, fV, fXIII, protein C, thrombinactivated fibrinolysis inhibitor), receptors (e.g., PARs, thrombomodulin, GPIbα) and inhibitors (e.g., antithrombin III, heparin cofactor II). 4 However, thrombin-mediated signaling events also control fundamental cellular functions, independent of hemostasis, in a large number of diverse cell types (e.g., endothelial cells 15 , fibroblasts 16 Finally, these data show that the loss of prothrombin, unlike the loss of either coagulation-or platelet-function alone, is not compatible with survival in adult animals.
The survival profile of Cre-negative fII lox/-mice illustrates that circulating prothrombin can be diminished substantially without significant hemostatic consequences, and may even hold some phenotypic benefits in the context of selected challenges (e.g. acute thrombotic insults, malignancy). This finding is compatible with an earlier finding 39 that transgenic mice expressing constitutively low levels (~7% of normal) of human prothrombin and no endogenous murine prothrombin survive well into adulthood without experiencing major bleeding events. However, the consequences of imposing a profound deficit in circulating prothrombin in unchallenged adult mice are rapid and fatal. The most prominent and highly-penetrant pathology observed was hemorrhagic events within the heart and brain, but evidence of bleeding was also often appreciated in the pleural cavity, skeletal muscle, and skin. Some of these tissues were also sites of bleeding and other pathological changes in adult mice expressing low levels (~1%) of either tissue factor or fVII 43, 45 , reduced activity of fX 44 , or deficient in fXIII. 46 In our study, pulmonary hemorrhage was not observed, as was seen in the low TF mice, but this may merely be a reflection of earlier and acute bleeding events elsewhere in conditional prothrombin-deficient mice. However, like mice with deficits in TF, fVII, fX, and fXIII, fII lox/-carrying low levels of fII in the absence of Cre recombination developed an agedependent process of modest cardiac hemorrhage (as evidenced by hemosiderin deposition), and modest fibrosis that was evident in most, albeit not all, mice by 1 year of age. However, the most significant distinction between prior findings in low TF, fVII, and fX mice and Mx + fII lox/-mice is that Cre-induced depletion of prothrombin in the latter results in profound cardiac pathologies, including subepicardial and myocardial hemorrhage, ischemia, inflammatory cell infiltrates and diffuse plasma and/or matrix protein deposition, regardless of gender, and within just days rather than over many months.
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The acute development of cardiac pathologies in fII lox mice following loss of circulating prothrombin offers some insight into the mechanism underlying the cardiac phenotype previously described in low TF and low fVII mice. The present findings suggest that the development of hemosiderin deposits and fibrosis in older low TF/fVIII mice is likely due to a chronic impediment in a thrombin-coupled process rather than the loss of a thrombin-independent TF/fVII signaling pathway. An attractive working hypothesis for the rapid development of cardiac pathologies in prothrombin-deficient adults is that the collapse of hemostatic function results in catastrophic hemorrhage in the heart under repetitive mechanical stress. Consistent with the concept of a broad failure of hemostasis, it is notable that the individual loss of any PAR, including PAR-1 or -4, does not result in cardiac pathologies in unchallenged adult mice. Similarly, the individual loss of fibrinogen also does not lead to spontaneous heart disease. Rather, the combination of hemostatic derangements associated with loss of either prothrombin or the capacity for thrombin activation appears to underlie hemorrhage and secondary fibrosis in the heart.
The proposal that tissues under recurrent mechanical stress may have a special requirement for an effective hemostatic system may provide an explanation for why some tissues (e.g., heart, skeletal muscle, skin), but not others (e.g., liver, spleen, kidneys), are prone to bleeding in the context of genetic or pharmacologic disruption of hemostatic factors. The need to have effective control of chance vascular breaks may also provide a rationale for the high levels of tissue factor expression observed in heart, lung and other tissues. 43, 48 The brain is a particularly rich source of TF and a previously recognized site of hemorrhage in older mice expressing low levels of TF/fVII. The finding that rapidonset, multi-focal hemorrhagic events in the brains of mice following conditional elimination of prothrombin again points to the critical role of TF/fVII in the control of thrombin generation in the brain. Like the heart, no brain pathologies have been recognized in adult mice lacking any of the PARs, suggesting that a failure of thrombin signaling alone does not account for CNS hemorrhage. At first glance, a failure at the level of loss of hemostatic function may appear to be equally unlikely because the highlyprotected brain would not seem to be subjected to recurrent mechanical insult. However, it should be noted that surgical exposure of the brain reveals an easily visible pulsation of
For personal use only. on May 4, 2017. by guest www.bloodjournal.org From brain tissue with every heart beat; a phenomenon that cannot be readily appreciated upon gross inspection of most other organs. 49 Therefore, it is conceivable that the unique, flexible and highly-vascularized structure of brain tissue may demand special hemostatic controls to counter chance vascular breaks associated with pulsatile motion. The potential importance of thrombin in brain vasculature integrity is further emphasized by the fact that thrombomodulin, the endothelial thrombin receptor that redirects thrombin activity away from procoagulant substrates, is distinctly absent within the brain vasculature. More detailed studies of the role of thrombin in the brain, particularly disease processes involving disruption of the neurovascular unit, may be highly revealing.
Antithrombotic strategies being developed at the level of fVIIa, fXa, thrombin, and other coagulation factors are likely to offer therapeutic benefits in multiple contexts, including acute thrombotic events (e.g., stroke, myocardial infarction), inflammatory diseases, and cancer. However, the present studies suggest that aggressive and/or long-term pharmacological strategies to limit thrombin generation or thrombin-mediated proteolysis may hold special risks in certain organs, particularly heart and brain. This is reinforced by the high incidence of spontaneous intracranial hemorrhage associated with certain anticoagulation or thrombolytic protocols.
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However, the fact that remarkably low prothrombin levels are well tolerated suggests that only the most aggressive forms of intervention must be approached with caution. The finding that prothrombin levels can be readily manipulated in fII lox mice and reduced by more than 90% without acute loss of vascular integrity or viability, provides an novel experimental opportunity to explore the prothrombin-dependence of virtually any physiological and pathological process. Of particular interest will be defining the precise contribution of prothrombin to tumor progression, vessel wall disease, sickle cell disease and inflammatory joint, lung, bowel and CNS disease. CFU of bacteria. Values are expressed as the mean ± SEM. Note that while a modest trend towards decreased bacterial clearance was observed in fII lox/lox animals in the absence of Cre recombination, the more profound diminution of circulating prothrombin associated with hepatic induction of Cre in Mx + fII lox/lox mice (5 days after poly I:C treatment) resulted in a dramatic impairment in the ability to clear peritoneal S. aureus (*P < 0.008 compared to wild-type; **P < 0.02 compared to wild-type) Representative cytospins of peritoneal lavage fluid collected 1 hour after infection from a Cre-induced Mx + fII lox/lox animal (5 days after poly I:C treatment) (B) and a wild-type mouse challenged in parallel (C). Note that cytospin preparations from animals lacking prothrombin (B) were characterized by both abundant clusters of free S. aureus and bacteria-engorged and disrupted phagocytes, whereas parallel preparations from control mice were largely clear of bacteria. Bars indicate 50 μm.
